LakePharma's 4th Protein Engineering Symposium Draws Record Attendance

SOUTH SAN FRANCISCO, Calif., Oct. 13, 2016 /PRNewswire/ -- The 4^th annual LakePharma Protein Engineering Symposium was held at the South San Francisco Conference Center on Oct. 7th. Over 300 local scientists attended the day-long event, featuring presentations from Stanford, local biotech companies including Atreca, GigaGen, and TeneoBio, and large pharma companies including Janssen, Pfizer and Grifols.  Presentations focused on new technologies in immune repertoire expression and analysis, rapid development of therapeutic antibodies, promises and challenges in developing bispecific antibodies, and methods in analyzing antibody epitopes. In addition to formal presentations, the symposium included special topic workshops, a poster session, and a happy hour for networking.

"This symposium has become a significant annual local event. We are extremely proud to provide the platform for scientists to learn and network with colleagues throughout the field," said Hua Tu, Ph.D, founder and CEO of LakePharma. "We truly appreciate the support from our distinguished speakers, attendees to the symposium, our customers, as well as service vendors who sponsored event. As the leading US biologics CRO, we strive to provide an integrated biologics service from discovery to development to manufacturing. We look forward to another record-breaking event in 2017." 

Click here for more information on the Symposium

About LakePharma, Inc.

LakePharma is a leading US-based contract research organization (CRO) specializing in antibody and protein engineering, cell line development, and protein production. Services can be fully integrated, creating a "soup to nuts" solution for all of a customer's molecular biology, cell line, and protein needs. With facilities located in the heart of the San Francisco Bay Area and near the Boston/Cambridge biotech hub, LakePharma has developed numerous in-house technology platforms to provide cost-effective and high quality services to our customers. Our production processes are SOP-based and high-throughput, and have been streamlined to be exceptionally efficient on both a small and large scale. Each project is actively managed by a dedicated study director and a project manager to ensure timely completion with superior results that meet or exceed our clients' expectations. For more information, visit www.lakepharma.com.

Corporate Communications Contact
Vickie Tu 650-288-4891

Logo - http://photos.prnewswire.com/prnh/20161013/428544LOGO

SOURCE LakePharma, Inc.